Felix Bergmann
Overview
Explore the profile of Felix Bergmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
69
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jorda A, Pracher L, Eberl S, Nussbaumer-Proll A, Sarhan M, Weber M, et al.
Med Microbiol Immunol
. 2025 Mar;
214(1):14.
PMID: 40047923
Whether the magnitude of individual cytokine, cellular, and clinical responses to the intravenous lipopolysaccharide (LPS) challenge is constant in individuals over extended time periods is unknown. Nine healthy volunteers received...
2.
Bergmann F, Prager M, Pracher L, Sawodny R, Steiner-Gager G, Richter B, et al.
J Intern Med
. 2025 Mar;
PMID: 40041991
Background: The optimal systolic blood pressure (SBP) target in patients with increased cardiovascular risk remains uncertain. This study evaluated the efficacy and safety of intensive SBP control (<120 mm Hg)...
3.
Jorda A, Prager M, Pracher L, Haselwanter P, Jackwerth M, Al Jalali V, et al.
J Infect
. 2025 Jan;
90(2):106405.
PMID: 39756693
Objectives: There is conflicting evidence as to whether the combined administration of two vaccines can lead to poorer immunogenicity and reactogenicity. The co-administration of the Omicron-adapted COVID-19 vaccine from Novavax...
4.
Sanz-Codina M, van Os W, Pham A, Jorda A, Wolf-Duchek M, Bergmann F, et al.
J Antimicrob Chemother
. 2024 Oct;
79(12):3281-3288.
PMID: 39373642
Background: Cefiderocol may potentially be used to treat skin and soft tissue infections (SSTIs). However, the pharmacokinetics of cefiderocol in human soft tissues have not yet been determined. The objective...
5.
Jorda A, Pecho T, Horvath L, Nishani E, Bull L, Bergmann F, et al.
Am J Med
. 2024 Sep;
138(1):61-69.e3.
PMID: 39284482
Objective: We aimed to investigate the association of electrocardiogram (ECG) findings with outcomes in patients with chronic coronary syndrome. Methods: This secondary analysis of the ISCHEMIA and ISCHEMIA-CKD trials divided...
6.
Jorda A, Eberl S, Nussbaumer-Proll A, Sarhan M, Weber M, Tegrovsky L, et al.
J Inflamm Res
. 2024 Jul;
17:4781-4790.
PMID: 39051050
Introduction: Lipopolysaccharide (LPS) stimulation of human whole blood ex vivo has been widely used to investigate human innate immune responses. However, there are uncertainties regarding the reproducibility and reliability of...
7.
Jorda A, Douglas I, Staudinger T, Heinz G, Bergmann F, Oberbauer R, et al.
Crit Care
. 2024 Jul;
28(1):231.
PMID: 38992663
Background: Early fluid management in patients with advanced chronic kidney disease (CKD) and sepsis-induced hypotension is challenging with limited evidence to support treatment recommendations. We aimed to compare an early...
8.
Gelbenegger G, Pecho T, Horvath L, Nishani E, Bull L, Bergmann F, et al.
Heart Rhythm
. 2024 Jul;
21(12):2613-2614.
PMID: 38960304
No abstract available.
9.
Borger A, Semmler L, Bergmann F, Supper P, Radtke C
J Burn Care Res
. 2024 Jul;
45(5):1336-1340.
PMID: 38953562
Here, we report about a patient with a full-thickness burn injury of the left lower extremity with approximately 8% of total BSA affected. Initial therapy consisted of necrosectomy and wound...
10.
Bergmann F, Jorda A, Sollner J, Sawodny R, Kammerer K, List V, et al.
Eur J Clin Microbiol Infect Dis
. 2024 Jun;
43(9):1731-1740.
PMID: 38922377
Purpose: Severe burn injuries are often accompanied by infections and associated with high morbidity and mortality. This study aimed to compare the prevalence and clinical impact of bacteremia between patients...